Our R2R March 2017 cyber-seminar introduced many of us to a specific genetic disorder - Lynch syndrome - that increases risk for certain types of cancer, including colorectal, endometrial (uterine), ovarian, and stomach cancer. Dr. David Chambers’ reflection on the NCI-hosted workshop on “Approaches to Blue Ribbon Panel Recommendations: The Case of Lynch Syndrome” was followed by three engaging presentations detailing current work on Lynch syndrome screening practices from Ms. Heather Hampel, Dr. Greg Feero, and Ms. Debra Duquette.
Now we want to invite you to join the discussion and share your perspective!
- Do you have questions for any of our presenters?
- Does your own work relate to Lynch syndrome? Do you have any “lessons learned” or best practices to share?
- What are some of the challenges and opportunities you see in regards to Lynch syndrome screening practices? How can we address these issues?
We look forward to reading your responses and continuing the conversation!
from the R2R team